Similar articles

• Scientists, officials eye tools aimed at combating abuse of painkillers.

  Kuehn BM. Kuehn BM. JAMA. 2012 Jan 4;307(1):19-21. doi: 10.1001/jama.2011.1900. JAMA. 2012. PMID: 22215154 No abstract available.
• FDA Boxed Warning for Immediate-Release Opioids.

  Food And Drug Administration Public Health Service U S Department Of Health And Human Services. Food And Drug Administration Public Health Service U S Department Of Health And Human Services. J Pain Palliat Care Pharmacother. 2016 Jun;30(2):141-5. doi: 10.3109/15360288.2016.1173762. J Pain Palliat Care Pharmacother. 2016. PMID: 27301692
• Can prescription drug monitoring programs help limit opioid abuse?

  Gugelmann HM, Perrone J. Gugelmann HM, et al. JAMA. 2011 Nov 23;306(20):2258-9. doi: 10.1001/jama.2011.1712. JAMA. 2011. PMID: 22110107 No abstract available.
• Class-wide REMS for extended-release and long-acting opioids: potential impact on pharmacies.

  Matthews ML. Matthews ML. J Am Pharm Assoc (2003). 2013 Jan-Feb;53(1):e1-7. doi: 10.1331/JAPhA.2013.12025. J Am Pharm Assoc (2003). 2013. PMID: 23636166 Review.
• First, do no harm: Advocating for opioid prescribing guidelines in Canadian emergency departments.

  Moore K, Lew J, Buttemer S, Kielstra L. Moore K, et al. CJEM. 2017 Jul;19(4):324-326. doi: 10.1017/cem.2017.8. Epub 2017 Mar 20. CJEM. 2017. PMID: 28318458 Review. No abstract available.